Common use of Service Components Clause in Contracts

Service Components. 7.1 The Provider must, as appropriate, provide the following Essential LTC Services to each Service User: (a) Dispensing Pharmaceuticals and providing Professional Advisory Services in accordance with clauses 3 to 6 of Schedule 1; (b) medicines reconciliation services, being that the Provider collects and compares information from Prescribers on the Service User’s medicines in order to identify the most accurate list of medicines the Service User is taking; (c) synchronisation services, being that the Provider coordinates the quantities of all the Service User’s medications Dispensed to the earliest common date so that the next prescription periods can be aligned; (d) reminder services, whereby the Provider provides each Service User with a reminder, in a form agreed with them, about when their next supply of Pharmaceuticals is to be collected; (e) regular screening of a Service User’s compliance with, and adherence to, their medicines regime and the provision of medicines alignment services, as further specified (if applicable) in the LTC Services Protocol; (f) Dispensing services, with Dispensing frequency tailored to the needs of the Service User and compliant with the requirements of the Pharmaceutical Schedule Rules; and (g) regular engagement, as deemed appropriate or agreed, with members of the Service User’s multidisciplinary care team, and in particular, engagement with their key medical practitioner(s), in order to provide the Service User's multidisciplinary care team with information about the Service User’s progress in improving the Service User's management of their medications and compliance and adherence with their medicines regime. 7.2 The Provider must regularly and proactively make contact with the Service User, with clear agreement about mutual expectations and the LTC Services available. 7.3 The LTC Services the Provider provides to each Service User must be supported by appropriate documentation, which the Provider must make available for Te Whatu Ora's inspection and Audit. 7.4 Te Whatu Ora and the Provider acknowledge that it may not be appropriate to provide all of the Essential LTC Services to a LTC Service User from the date that Services User is approved to receive LTC Services. 7.5 The Provider must follow the process set out in the LTC Services Protocol for transitioning a Service User on to the appropriate Essential LTC Services. 7.6 Without limiting clause D.22, the Provider must not refer a LTC Service User to another provider for that provider to provide Dispensing Services to the LTC Service User, unless otherwise expressly permitted under this Agreement or if the Provider needs to make an onward referral in an emergency situation in which the Provider is unable to provide urgently needed medication.

Service Components. 7.1 4.1 The Provider must, as appropriate, must provide Opioid Substitution Treatment Services in accordance with the following Essential LTC Services to each Service Userrequirements: (a) Dispensing Pharmaceuticals and providing Professional Advisory Services the relevant clauses in accordance with clauses 3 to 6 Schedule 1, in particular clause 9 of Schedule 1; (b) medicines reconciliation services, being that the protocol issued by Te Whatu Ora concerning community dispensing of methadone or buprenorphine+naloxone; and (c) any written agreements the Provider collects and compares information may develop with Service Users receiving Opioid Substitution Treatment Services from Prescribers the Provider in accordance with the Opioid Substitution Treatment New Zealand Practice Guidelines. 4.2 The services the Provider must provide, as part of providing Opioid Substitution Treatment Services, include: (a) providing methadone or buprenorphine+naloxone pursuant to Prescription Forms issued by an opioid substitution treatment service, or by authorised Prescribers; (b) supervising the daily consumption of "consume on premises" methadone or buprenorphine+naloxone doses when the Service User’s medicines in order to identify the most accurate list of medicines the Service User Provider's Premises is takingopen; (c) synchronisation servicesarranging for the collection of "takeaway doses" for the days when the Provider's Premises is closed, being that if these have been specifically requested by the Provider coordinates the quantities of all the Service User’s medications Dispensed to the earliest common date so that the next prescription periods can be alignedPrescriber; (d) reminder services, whereby ensuring that all methadone or buprenorphine+naloxone Dispensed by the Provider provides each Service User as "takeaway doses" is Dispensed in secure containers and packaging and in accordance with a reminder, in a form agreed with them, about when their next supply of Pharmaceuticals is to be collectedthe Provider's written policy; (e) regular screening of a advising and assisting Service User’s Users and Prescribers to enhance compliance with, and adherence to, their medicines regime and the provision of medicines alignment services, as further specified (if applicable) in the LTC Services Protocol;with all concurrent prescribed medicines; and (f) Dispensing servicesdeveloping and implementing a written protocol that sets out how the Provider will liaise with an opioid substitution treatment service and prescribing general practitioners on a regular basis, with Dispensing frequency tailored in a manner appropriate to the needs of the Provider's Service User and compliant with the requirements Users, including statements about communications regarding verification of the Pharmaceutical Schedule Rules; and (g) regular engagementdoses, as deemed appropriate or agreedside-effects, with members of the complaints about Service User’s multidisciplinary care teamUsers, and in particular, engagement with their key medical practitioner(s), in order to provide the Service User's multidisciplinary care team with information about the Service User’s progress in improving the Service User's management of their medications and compliance and adherence with their medicines regimeany difficulties arising as a result. 7.2 The Provider must regularly and proactively make contact with the Service User, with clear agreement about mutual expectations and the LTC Services available. 7.3 The LTC Services the Provider provides to each Service User must be supported by appropriate documentation, which the Provider must make available for Te Whatu Ora's inspection and Audit. 7.4 Te Whatu Ora and the Provider acknowledge that it may not be appropriate to provide all of the Essential LTC Services to a LTC Service User from the date that Services User is approved to receive LTC Services. 7.5 The Provider must follow the process set out in the LTC Services Protocol for transitioning a Service User on to the appropriate Essential LTC Services. 7.6 Without limiting clause D.22, the Provider must not refer a LTC Service User to another provider for that provider to provide Dispensing Services to the LTC Service User, unless otherwise expressly permitted under this Agreement or if the Provider needs to make an onward referral in an emergency situation in which the Provider is unable to provide urgently needed medication.

Service Components. 7.1 4.1 The Provider must, as appropriate, must provide Opioid Substitution Treatment Services in accordance with the following Essential LTC Services to each Service Userrequirements: (a) Dispensing Pharmaceuticals and providing Professional Advisory Services the relevant clauses in accordance with clauses 3 to 6 Schedule 1, in particular clause 9 of Schedule 1; (b) medicines reconciliation services, being that the protocol issued by the Ministry concerning community dispensing of methadone or buprenorphine+naloxone; and (c) any written agreements the Provider collects and compares information may develop with Service Users receiving Opioid Substitution Treatment Services from Prescribers the Provider in accordance with the Opioid Substitution Treatment New Zealand Practice Guidelines. 4.2 The services the Provider must provide, as part of providing Opioid Substitution Treatment Services, include: (a) providing methadone or buprenorphine+naloxone pursuant to Prescription Forms issued by an opioid substitution treatment service, or by authorised Prescribers; (b) supervising the daily consumption of "consume on premises" methadone or buprenorphine+naloxone doses when the Service User’s medicines in order to identify the most accurate list of medicines the Service User Provider's Premises is takingopen; (c) synchronisation servicesarranging for the collection of "takeaway doses" for the days when the Provider's Premises is closed, being that if these have been specifically requested by the Provider coordinates the quantities of all the Service User’s medications Dispensed to the earliest common date so that the next prescription periods can be alignedPrescriber; (d) reminder services, whereby ensuring that all methadone or buprenorphine+naloxone Dispensed by the Provider provides each Service User as "takeaway doses" is Dispensed in secure containers and packaging and in accordance with a reminder, in a form agreed with them, about when their next supply of Pharmaceuticals is to be collectedthe Provider's written policy; (e) regular screening of a advising and assisting Service User’s Users and Prescribers to enhance compliance with, and adherence to, their medicines regime and the provision of medicines alignment services, as further specified (if applicable) in the LTC Services Protocol;with all concurrent prescribed medicines; and (f) Dispensing servicesdeveloping and implementing a written protocol that sets out how the Provider will liaise with an opioid substitution treatment service and prescribing general practitioners on a regular basis, with Dispensing frequency tailored in a manner appropriate to the needs of the Provider's Service User and compliant with the requirements Users, including statements about communications regarding verification of the Pharmaceutical Schedule Rules; and (g) regular engagementdoses, as deemed appropriate or agreedside-effects, with members of the complaints about Service User’s multidisciplinary care teamUsers, and in particular, engagement with their key medical practitioner(s), in order to provide the Service User's multidisciplinary care team with information about the Service User’s progress in improving the Service User's management of their medications and compliance and adherence with their medicines regimeany difficulties arising as a result. 7.2 The Provider must regularly and proactively make contact with the Service User, with clear agreement about mutual expectations and the LTC Services available. 7.3 The LTC Services the Provider provides to each Service User must be supported by appropriate documentation, which the Provider must make available for Te Whatu Ora's inspection and Audit. 7.4 Te Whatu Ora and the Provider acknowledge that it may not be appropriate to provide all of the Essential LTC Services to a LTC Service User from the date that Services User is approved to receive LTC Services. 7.5 The Provider must follow the process set out in the LTC Services Protocol for transitioning a Service User on to the appropriate Essential LTC Services. 7.6 Without limiting clause D.22, the Provider must not refer a LTC Service User to another provider for that provider to provide Dispensing Services to the LTC Service User, unless otherwise expressly permitted under this Agreement or if the Provider needs to make an onward referral in an emergency situation in which the Provider is unable to provide urgently needed medication.

Service Components. 7.1 4.1 The Provider must, as appropriate, must provide Opioid Substitution Treatment Services in accordance with the following Essential LTC Services to each Service Userrequirements: (a) Dispensing Pharmaceuticals and providing Professional Advisory Services the relevant clauses in accordance with clauses 3 to 6 Schedule 1, in particular clause 9 of Schedule 1; (b) medicines reconciliation services, being that the protocol issued by Health NZ concerning community dispensing of methadone or buprenorphine+naloxone; and (c) any written agreements the Provider collects and compares information may develop with Service Users receiving Opioid Substitution Treatment Services from Prescribers the Provider in accordance with the Opioid Substitution Treatment New Zealand Practice Guidelines. 4.2 The services the Provider must provide, as part of providing Opioid Substitution Treatment Services, include: (a) providing methadone or buprenorphine+naloxone pursuant to Prescription Forms issued by an opioid substitution treatment service, or by authorised Prescribers; (b) supervising the daily consumption of "consume on premises" methadone or buprenorphine+naloxone doses when the Service User’s medicines in order to identify the most accurate list of medicines the Service User Provider's Premises is takingopen; (c) synchronisation servicesarranging for the collection of "takeaway doses" for the days when the Provider's Premises is closed, being that if these have been specifically requested by the Provider coordinates the quantities of all the Service User’s medications Dispensed to the earliest common date so that the next prescription periods can be alignedPrescriber; (d) reminder services, whereby ensuring that all methadone or buprenorphine+naloxone Dispensed by the Provider provides each Service User as "takeaway doses" is Dispensed in secure containers and packaging and in accordance with a reminder, in a form agreed with them, about when their next supply of Pharmaceuticals is to be collectedthe Provider's written policy; (e) regular screening of a advising and assisting Service User’s Users and Prescribers to enhance compliance with, and adherence to, their medicines regime and the provision of medicines alignment services, as further specified (if applicable) in the LTC Services Protocol;with all concurrent prescribed medicines; and (f) Dispensing servicesdeveloping and implementing a written protocol that sets out how the Provider will liaise with an opioid substitution treatment service and prescribing general practitioners on a regular basis, with Dispensing frequency tailored in a manner appropriate to the needs of the Provider's Service User and compliant with the requirements Users, including statements about communications regarding verification of the Pharmaceutical Schedule Rules; and (g) regular engagementdoses, as deemed appropriate or agreedside-effects, with members of the complaints about Service User’s multidisciplinary care teamUsers, and in particular, engagement with their key medical practitioner(s), in order to provide the Service User's multidisciplinary care team with information about the Service User’s progress in improving the Service User's management of their medications and compliance and adherence with their medicines regimeany difficulties arising as a result. 7.2 The Provider must regularly and proactively make contact with the Service User, with clear agreement about mutual expectations and the LTC Services available. 7.3 The LTC Services the Provider provides to each Service User must be supported by appropriate documentation, which the Provider must make available for Te Whatu Ora's inspection and Audit. 7.4 Te Whatu Ora and the Provider acknowledge that it may not be appropriate to provide all of the Essential LTC Services to a LTC Service User from the date that Services User is approved to receive LTC Services. 7.5 The Provider must follow the process set out in the LTC Services Protocol for transitioning a Service User on to the appropriate Essential LTC Services. 7.6 Without limiting clause D.22, the Provider must not refer a LTC Service User to another provider for that provider to provide Dispensing Services to the LTC Service User, unless otherwise expressly permitted under this Agreement or if the Provider needs to make an onward referral in an emergency situation in which the Provider is unable to provide urgently needed medication.

Service Components. 7.1 4.1 The Provider must, as appropriate, must provide Opioid Substitution Treatment Services in accordance with the following Essential LTC Services to each Service Userrequirements: (a) Dispensing Pharmaceuticals the relevant clauses in Schedules 1 and providing Professional Advisory Services 2, in accordance with particular, clauses 3 2 to 6 5 of Schedule 1, and clauses 2 to 5 of Schedule 2; (b) medicines reconciliation services, being that the protocol issued by the Ministry concerning community pharmacist dispensing of methadone orbuprenorphine+naloxone; and (c) any written agreements the Provider collects and compares information may develop with Service Users receiving Opioid Substitution Treatment Services from Prescribers the Provider in accordance with the Opioid Substitution Treatment New Zealand Practice Guidelines. 4.2 The services the Provider must provide, as part of providing Opioid Substitution Treatment Services, include: (a) providing methadone or buprenorphine+naloxone pursuant to Prescription Forms issued by an opioid substitution treatment service, or by authorised Prescribers; (b) supervising the daily consumption of "consume on premises" methadone or buprenorphine+naloxone doses when the Service User’s medicines in order to identify the most accurate list of medicines the Service User Provider's Premises is takingopen; (c) synchronisation servicesarranging for the collection of "takeaway doses" for the days when the Provider's Premises is closed, being that if these have been specifically requested by the Provider coordinates the quantities of all the Service User’s medications Dispensed to the earliest common date so that the next prescription periods can be alignedPrescriber; (d) reminder services, whereby ensuring that all methadone or buprenorphine+naloxone Supplied by the Provider provides each Service User as "takeaway doses" is Supplied in containers with a reminder, safety caps and in a form agreed accordance with them, about when their next supply of Pharmaceuticals is to be collectedthe Provider's written policy; (e) regular screening of a advising and assisting Service User’s Users and Prescribers to enhance compliance with, and adherence to, their medicines regime and the provision of medicines alignment services, as further specified (if applicable) in the LTC Services Protocol;with all concurrent prescribed medicines; and (f) Dispensing servicesdeveloping and implementing a written protocol that sets out how the Provider will liaise with an opioid substitution treatment service and prescribing general practitioners on a regular basis, with Dispensing frequency tailored in a manner appropriate to the needs of the Provider's Service User and compliant with the requirements Users, including statements about communications regarding verification of the Pharmaceutical Schedule Rules; and (g) regular engagementdoses, as deemed appropriate or agreedside-effects, with members of the complaints about Service User’s multidisciplinary care teamUsers, and in particular, engagement with their key medical practitioner(s), in order to provide the Service User's multidisciplinary care team with information about the Service User’s progress in improving the Service User's management of their medications and compliance and adherence with their medicines regimeany difficulties arising. 7.2 The Provider must regularly and proactively make contact with the Service User, with clear agreement about mutual expectations and the LTC Services available. 7.3 The LTC Services the Provider provides to each Service User must be supported by appropriate documentation, which the Provider must make available for Te Whatu Ora's inspection and Audit. 7.4 Te Whatu Ora and the Provider acknowledge that it may not be appropriate to provide all of the Essential LTC Services to a LTC Service User from the date that Services User is approved to receive LTC Services. 7.5 The Provider must follow the process set out in the LTC Services Protocol for transitioning a Service User on to the appropriate Essential LTC Services. 7.6 Without limiting clause D.22, the Provider must not refer a LTC Service User to another provider for that provider to provide Dispensing Services to the LTC Service User, unless otherwise expressly permitted under this Agreement or if the Provider needs to make an onward referral in an emergency situation in which the Provider is unable to provide urgently needed medication.